Search

everythinglearnresearchcommunity

for

Search:↓

Tea tree oil is more effective for treating human demodicosis than other treatments.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

Tea tree oil may help treat scalp alopecia by promoting hair follicle stem cell growth.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

The frizzy mouse and hairless rat mutations are due to changes in the Prss8 gene.

The normal human prostate does not significantly affect blood DHT levels.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

DHT affects testicular development and regulates spermatogenesis in some fish.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

A genetic mutation in the hHa1 gene creates a smaller, but still functional, hair protein without causing hair problems.

Temporal hair loss relates to overall scalp hair loss in women.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Interleukin-6 may play a role in causing alopecia areata.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.